Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Andres Mendez Hernandez"'
Autor:
Vatsala Katiyar, Alok Uprety, Andres Mendez-Hernandez, Harry E. Fuentes, Xavier A. Andrade, Maryam Zia
Publikováno v:
TH Open, Vol 03, Iss 03, Pp e203-e209 (2019)
Abstract Background Patients with Philadelphia-negative myeloproliferative neoplasms (MPNs), including polycythemia vera (PV), essential thrombocytosis (ET), and primary myelofibrosis (MF), have a significant risk of venous thromboembolism (VTE). W
Externí odkaz:
https://doaj.org/article/484fa2f7f0f241708bb4a06dba121805
Publikováno v:
Current Oncology Reports.
Purpose of Review This article summarizes the current state of knowledge of hairy cell leukemia (HCL) regarding presentation, diagnosis, therapy, and monitoring, including perspectives on emergent therapies. Recent Findings Over the past decade, ther
Autor:
Harry E Fuentes, Alok Uprety, Vatsala Katiyar, Andres Mendez-Hernandez, Maryam Zia, Xavier A Andrade
Publikováno v:
TH Open: Companion Journal to Thrombosis and Haemostasis
TH Open, Vol 03, Iss 03, Pp e203-e209 (2019)
TH Open, Vol 03, Iss 03, Pp e203-e209 (2019)
Background Patients with Philadelphia-negative myeloproliferative neoplasms (MPNs), including polycythemia vera (PV), essential thrombocytosis (ET), and primary myelofibrosis (MF), have a significant risk of venous thromboembolism (VTE). We aim to de
Publikováno v:
Transplantation and Cellular Therapy. 27:S238
Autor:
Christian Torres, Ezequiel Munoz, Juan Del Cid, Xavier Alberto Andrade Gonzalez, Andres Mendez Hernandez, Vatsala Katiyar, Luis David Sumoza
Publikováno v:
Journal of Clinical Oncology. 37:6570-6570
6570 Background: Patients with multiple myeloma (MM) who are part of racial/ethnic minority groups have been typically underrepresented in large descriptive and randomized-controlled studies. Despite the identification of biological and genetic risk
Autor:
Andres Mendez Hernandez, Alfonso Tafur, Roberto A. Leon-Ferre, Harry Eduardo Fuentes Bayne, Xavier Alberto Andrade Gonzalez, Hashim Mann
Publikováno v:
Journal of Clinical Oncology. 36:e19546-e19546
e19546Background: Up to 16% of patients with diffuse large B-cell lymphoma (DLBCL) will develop venous thromboembolism (VTE), which is associated with increased healthcare expenditure. However, ann...
Autor:
Roberto A. Leon-Ferre, Harry Eduardo Fuentes Bayne, Hashim Mann, Alfonso Tafur, Xavier Alberto Andrade Gonzalez, Andres Mendez Hernandez
Publikováno v:
Journal of Clinical Oncology. 36:e19030-e19030
e19030Background: Patients with Philadelphia-negative myeloproliferative neoplasms (MPN), including polycythemia vera (PV), essential thrombocytosis (ET) and primary myelofibrosis (MF), have a sign...